Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography

被引:7
|
作者
Jemaa, Skander [1 ]
Ounadjela, Souhila [1 ]
Wang, Xiaoyong [1 ]
El-Galaly, Tarec C. [2 ,3 ,4 ,5 ]
Kostakoglu, Lale [6 ]
Knapp, Andrea [7 ]
Ku, Grace [1 ]
Musick, Lisa [1 ]
Sahin, Denis [7 ]
Wei, Michael C. [1 ]
Yin, Shen [1 ]
Bengtsson, Thomas [8 ]
De Crespigny, Alex [1 ]
Carano, Richard A. D. [1 ]
机构
[1] Genentech Inc, South San Francisco, CA 94080 USA
[2] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark
[3] Odense Univ Hosp, Dept Hematol, Hematol Res Unit, Odense, Denmark
[4] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[5] AI Sweden, Lund, Sweden
[6] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA
[7] F Hoffmann La Roche, Basel, Switzerland
[8] Univ Calif Berkeley, Dept Stat, Berkeley, CA USA
关键词
ARTIFICIAL-INTELLIGENCE; LUNG-CANCER; PET/CT; DLBCL; CONSENSUS; CRITERIA;
D O I
10.1200/JCO.23.01978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE Artificial intelligence can reduce the time used by physicians on radiological assessments. For F-18-fluorodeoxyglucose-avid lymphomas, obtaining complete metabolic response (CMR) by end of treatment is prognostic. METHODS Here, we present a deep learning-based algorithm for fully automated treatment response assessments according to the Lugano 2014 classification. The proposed four-stage method, trained on a multicountry clinical trial (ClinicalTrials.gov identifier: NCT01287741) and tested in three independent multicenter and multicountry test sets on different non-Hodgkin lymphoma subtypes and different lines of treatment (ClinicalTrials.gov identifiers NCT02257567, NCT02500407; 20% holdout in ClinicalTrials.gov identifier NCT01287741), outputs the detected lesions at baseline and follow-up to enable focused radiologist review. RESULTS The method's response assessment achieved high agreement with the adjudicated radiologic responses (eg, agreement for overall response assessment of 93%, 87%, and 85% in ClinicalTrials.gov identifiers NCT01287741, NCT02500407, and NCT02257567, respectively) similar to inter-radiologist agreement and was strongly prognostic of outcomes with a trend toward higher accuracy for death risk than adjudicated radiologic responses (hazard ratio for end of treatment by-model CMR of 0.123, 0.054, and 0.205 in ClinicalTrials.gov identifiers NCT01287741, NCT02500407, and NCT02257567, compared with, respectively, 0.226, 0.292, and 0.272 for CMR by the adjudicated responses). Furthermore, a radiologist review of the algorithm's assessments was conducted. The radiologist median review time was 1.38 minutes/assessment, and no statistically significant differences were observed in the level of agreement of the radiologist with the model's response compared with the level of agreement of the radiologist with the adjudicated responses. CONCLUSION These results suggest that the proposed method can be incorporated into radiologic response assessment workflows in cancer imaging for significant time savings and with performance similar to trained medical experts.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Is there a role for bone scan in Hodgkin lymphoma in the age of 18F-fluorodeoxyglucose positron emission tomography?
    Martin, Peter
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1731 - 1732
  • [32] Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma
    Blum, RH
    Seymour, JF
    Wirth, A
    MacManus, M
    Hicks, RJ
    CLINICAL LYMPHOMA, 2003, 4 (01): : 43 - 49
  • [33] Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
    Spaepen, K
    Stroobants, S
    Dupont, P
    Vandenberghe, P
    Thomas, J
    de Groot, T
    Balzarini, J
    De Wolf-Peeters, C
    Mortelmans, L
    Verhoef, G
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1356 - 1363
  • [34] Impact of [18F] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma
    Wirth, Andrew
    Foo, Marcus
    Seymour, John F.
    Macmanus, Michael P.
    Hicks, Rodney J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : 213 - 219
  • [35] Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography
    Bodet-Milin, Caroline
    Kraeber-Bodere, Francoise
    Dupas, Benoit
    Morschhauser, Franck
    Gastinne, Thomas
    Le Gouill, Steven
    Campion, Loic
    Harousseau, Jean-Luc
    Wegener, William A.
    Goldenberg, David M.
    Huglo, Damien
    HAEMATOLOGICA, 2008, 93 (03) : 390 - 397
  • [36] An interesting case of F-18 fluorodeoxyglucose positron emission tomography avid renal oncocytoma
    Raman, Avi
    Campbell, Timothy
    McLeod, Nicholas
    ANZ JOURNAL OF SURGERY, 2016, 86 (1-2) : 99 - 100
  • [37] Does 18F-Fluorodeoxyglucose Outperform 18F-Fluorothymidine When Using Positron Emission Tomography in Predicting Transformation of Indolent Non-Hodgkin's Lymphoma
    Wondergem, Marielle
    Zijlstra, Josee
    Hoetjes, Nikie
    Chamuleau, Martine E. D.
    Zweegman, Sonja
    Huijgens, Peter C.
    Boellaard, Ronald
    Hoekstra, Otto S.
    BLOOD, 2011, 118 (21) : 1563 - 1564
  • [38] Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma
    Kawamura, Etsushi
    Shiomi, Susumu
    Kotani, Kohei
    Kawabe, Joji
    Hagihara, Atsushi
    Fujii, Hideki
    Uchida-Kobayashi, Sawako
    Iwai, Shuji
    Morikawa, Hiroyasu
    Enomoto, Masaru
    Murakami, Yoshiki
    Tamori, Akihiro
    Kawada, Norifumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (09) : 1722 - 1727
  • [39] The role of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
    Cheol Won Hyeon
    Hyun Kyung Yi
    Eun Kyoung Kim
    Sung-Ji Park
    Sang-Chol Lee
    Seung Woo Park
    Jae K. Oh
    Joon Young Choi
    Sung-A Chang
    Scientific Reports, 10
  • [40] The role of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
    Hyeon, Cheol Won
    Yi, Hyun Kyung
    Kim, Eun Kyoung
    Park, Sung-Ji
    Lee, Sang-Chol
    Park, Seung Woo
    Oh, Jae K.
    Choi, Joon Young
    Chang, Sung-A
    SCIENTIFIC REPORTS, 2020, 10 (01)